Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.
about
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived XenograftsMolecular and clinical implementations of ovarian cancer mouse avatar modelsPrioritizing therapeutic targets using patient-derived xenograft modelsPrevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts.Endothelial cells do not arise from tumor-initiating cells in human hepatocellular carcinoma.Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testingSetting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps.The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient miceHuman cancer growth and therapy in immunodeficient mouse models.Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic TumorsPatient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesEstablishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer.Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens.Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice.Barriers to generating PDX models of HPV-related head and neck cancer.Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.High-throughput flow cytometry screening of human hepatocellular carcinoma reveals CD146 to be a novel marker of tumor-initiating cells.Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program.Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments.Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts.Analysis of circulating tumor cells derived from advanced gastric cancer.Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC.Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.
P2860
Q26772895-EF891FA2-CC6D-4519-B0E8-61C3CF67F040Q26786724-E17FFD96-6398-47CE-A987-6B9296F46016Q28083993-5D15CBF8-DFB9-4D6C-8894-0252A5C75EA8Q33842769-B0E8DB5C-B319-4E99-AB28-86FBD3027600Q35020519-AC994BFE-3202-43C3-8BDA-91AD96F2B585Q35041892-80BA4AE3-55EF-4D8B-9486-03501BA9CCD9Q35084915-962F5087-79C0-4366-BD91-32370002F540Q35227197-D86EBC34-F1D8-4343-AE05-0BB61DB23288Q35545282-56B24327-E9F3-42D3-BD69-A3FBB5C3C0D3Q36177642-84980951-D9B3-49A2-B2AA-E7CF16952147Q36356386-C757A1A9-FAD2-488C-859A-A479DD1EE755Q36633405-9D80FF24-5FB2-4834-8F39-2B628802C701Q37580377-AD5B56AA-676C-4B33-8193-2DCF149D8FE1Q37604978-D5655F3A-81E7-4AE2-8284-A0FF9D106BEBQ40179397-64C310ED-5711-4DA3-BF80-397DDBBF33B3Q40416521-C7857EBB-3764-4F9A-A9D8-141BF16AE38FQ41658087-0862A358-887B-441C-8CB5-B3F60291610DQ41682711-C30892D7-C668-4DE7-A2AF-C0EA11359D81Q42175087-51693A67-8B0A-4449-B4A0-5928D613E82BQ45324743-C9E4CE13-6453-4458-8B79-2991ECED6956Q50185605-284AA03C-CA32-4906-81A6-6FF5B6A87402Q52638232-736E3A32-6B0C-4DF9-AE8B-BDA94B71BD8CQ52966216-5532771A-5B0C-4A33-B045-FD721995CF64Q52972537-74D050E1-4B13-48D9-A6B8-3A1A003A00FCQ53697578-A5C5C384-5C65-4315-8E3B-96AF0448E8D5Q55380373-60C6C6E0-48FC-41F7-A96E-42438177F701
P2860
Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@ast
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@en
type
label
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@ast
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@en
prefLabel
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@ast
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@en
P2093
P2860
P1433
P1476
Human solid tumor xenografts i ...... iated with Epstein-Barr virus.
@en
P2093
Anand Ghanekar
Sharif Ahmed
P2860
P304
P356
10.1371/JOURNAL.PONE.0039294
P407
P577
2012-06-18T00:00:00Z